Acadia Healthcare, a leading behavioral healthcare provider with 279 facilities, continues to grow its revenue and patient base. However, profitability is challenged by increasing labor costs and a tight labor market. Despite higher debt levels and volatile cash flows, the company's shares are considered attractively priced on an absolute basis. The analyst rates Acadia Healthcare a very soft buy due to its growth potential, valuation, and long-term demand drivers in the behavioral health sector.
Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti, Jr., is investigating Acadia Healthcare following the company's disclosure of a U.S. Attorney's Office inquiry and grand jury subpoena related to its admissions, length...
Acadia Healthcare (ACHC) is rated a BUY due to its robust capacity expansion pipeline and the increasing demand for mental health services in the US. As the largest independent behavioral healthcare provider with 279 facilities and 12,600 beds, ACHC ...
